Dr. James Harvey Paxton, MD

Dr. Paxton practices at Dmc Sinai - Grace Hospital in Detroit, Michigan.

Dr. Paxton's NPI, 1063622793, was assigned on May 23, 2007. Dr. Paxton holds Michigan license 4301085999.

Dr. Paxton's primary practice is Dmc Sinai - Grace Hospital, at 6071 W Outer Dr, Detroit, MI 48235 in Wayne County. The practice phone is (313) 966-2026.

Dr. Paxton's primary practice is Dmc Sinai - Grace Hospital in Detroit, Michigan. Dr. Paxton is also affiliated with Henry Ford Hospital. The medical group on file is Medical Center Emergency Services.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paxton practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Paxton's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Paxton is licensed in Michigan.

CMS data shows 187 Medicare services from Dr. Paxton across 4 procedure codes in 2024, for 139 Medicare patients. Medicare paid $17,909 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 139 Medicare patients who saw Dr. Paxton in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high blood pressure, and 65% have high cholesterol. 75% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Paxton's median patient age at 43, with 49% women.

In 2024, Dr. Paxton wrote 60 Medicare Part D claims for 36 patients. 97% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $48 in total drug cost. In 2022, CMS named 15 claims across 1 drug.

Dmand AI links 42 papers to Dr. Paxton, published from 2017 to 2025. 2023 was the busiest year, with 8. The most frequent topics are COVID-19, Emergency Service, Hospital and COVID-19 Serotherapy. Dr. Paxton has published most often in Resuscitation. Dr. Paxton's most frequent co-authors are Yuriko Fukuta, MD, Barry Ross Meisenberg, MD and Bela Patel, MD.

Dmand AI links Dr. Paxton to 4 clinical trials, 3 of them phase 2 studies. Conditions studied include COVID-19, Pneumonia, Viral and Anemia, Sickle Cell. Johns Hopkins University sponsors the most, 2.

CMS Open Payments shows 23 general payments to Dr. Paxton from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 44% of the total. Vertex Pharmaceuticals Incorporated paid the most, $5,661.